Related Experiment Videos
Inhibition of IgG-triggered human eosinophil function by IL-4
P Baskar1, D S Silberstein, S H Pincus
1Department of Dermatology, New England Medical Center Hospital, Boston, MA.
Journal of Immunology (Baltimore, Md. : 1950)
|March 15, 1990
Summary
Interleukin-4 (IL-4) suppresses key functions of eosinophils, specifically those triggered by Immunoglobulin G (IgG) receptors. This finding reveals a T lymphocyte mechanism for regulating eosinophil activity in inflammatory conditions.
Area of Science:
- Immunology
- Cell Biology
- Allergy and Inflammation Research
Background:
- Eosinophil functions, including secretion and cytotoxicity, are critical in tissue eosinophilia.
- These functions are typically triggered by Fc receptors for Immunoglobulin G (IgG) and Immunoglobulin E (IgE).
Purpose of the Study:
- To investigate the regulatory role of human recombinant Interleukin-4 (rIL-4) on human eosinophil triggering via Fc receptors.
- To elucidate the specific mechanisms by which IL-4 influences eosinophil responses.
Main Methods:
- Human eosinophils were preincubated with varying doses of IL-4.
- Eosinophil secretion of beta-glucuronidase and arylsulfatase was measured after stimulation with IgG- or IgE-coated beads.
- Antibody-dependent killing of schistosomula targets was assessed.
- Flow microfluorimetry was used to analyze Fc receptor expression.
Main Results:
- IL-4 significantly suppressed eosinophil secretion of beta-glucuronidase and arylsulfatase (up to 65%) upon stimulation with IgG-coated beads, requiring prolonged preincubation.
- IL-4 did not affect enzyme secretion stimulated by IgE-coated beads.
- IL-4 suppressed antibody-dependent killing of schistosomula targets by 24-39%.
- IL-4 reduced the expression of IgG Fc receptors but not IgE Fc receptors on eosinophils.
Conclusions:
- IL-4 effectively suppresses IgG-mediated eosinophil secretory and cytotoxic functions.
- The mechanism involves the downregulation of IgG Fc receptor expression.
- These findings highlight a pathway for T lymphocyte-mediated regulation of eosinophil activity in inflammatory diseases.